Heart Rate Variability (HRV) Biofeedback to Treat Ulcerative Colitis

Heart Rate Variability Biofeedback in the Treatment of Ulcerative Colitis

This is a prospective interventional study exploring the modifiability of physiological metrics, namely Heart Rate Variability (HRV), using a 5-week standardized HRV biofeedback intervention in subjects with symptomatic ulcerative colitis. Participants will be followed for 17 weeks. The goal is the understand if modifying these markers can impact ulcerative colitis related symptoms.

Inclusion Criteria:

• Adult subjects (18-65 years old)
• Ulcerative colitis with a symptomatic flare (SCCAI ≥3) and without inflammation (FC<250µg/ml)

Exclusion Criteria:

• Individuals who take medications known to alter heart rate variability
• Individuals with pacemakers or other implantable devices